GALNT14 and head and neck squamous cell carcinoma: The survival probability of GALNT14-rs9679162 GG genotype was significantly lower in the radiotherapy group (Figure 1c) of HNSCC patients, in the chemotherapy group of OSCC patients (Figure 1d), and in the radiotherapy and chemotherapy groups of LSCC patients (Figure 1f).